Navigation Links
Nanogea Announces New Scientific Advisory Board Members
Date:10/9/2009

Nanogea Adds Drs. C. Thomas Caskey and Saul Tendler to its Scientific Advisory Board

Westlake Village, Calif. (PRWEB) October 9, 2009 -- Nanogea, a nano-biotech company focused on commercializing the industry's most sensitive single molecular detection platform, is pleased to announce today that Dr. C. Thomas Caskey and Dr. Saul Tendler have joined its scientific advisory board.

Dr. Caskey is a prominent medical geneticist and biomedical entrepreneur. Dr. Caskey presently serves as Director and Chief Executive Officer of the Brown Foundation Institute of Molecular Medicine, a research institute that seeks to investigate the cause of human diseases at the cellular and molecular levels using DNA and protein technologies to expose disease mechanisms. He is a former founding Director and CEO of Cogene Biotech Ventures, venture capital funds designed to support early-stage biotechnology and life science companies. Dr. Caskey is a former SVP for Res. at Merck and Trustee and President of the Merck Genome Res. Inst. as well as an Ex-Chief of Section of Medical Genetics and Professor of Medicine and Biochemistry, Baylor College of Medicine. He sits on the boards of Essex Woodlands Health Ventures, Luminex, Odyssey Thera, En Vivo, Metabolon, Genome Canada, LabCorp. of America, and Vice Chair of Genome Canada. Dr. Caskey is a member of the Academy of Medicine, Engineering and Science of Texas (President of TAMEST 2004-05), a member of the National Academy of Sciences, and the Institute of Medicine. Dr. Caskey received his medical doctorate from Duke University. He is Board certified in Internal Medicine, Clinical Genetics, Metabolic Diseases, and Molecular Diagnostics.

Dr. Saul Tendler is Pro-Vice-Chancellor, Professor of Biophysical Chemistry and Head of the School of Pharmacy, University of Nottingham. His expertise is in the field of biophysical chemistry, with a particular focus on analysis of biomolecular systems and their interactions. Dr. Tendler is a Fellow of the Royal Society of Chemistry, and was designated a Fellow of the Royal Pharmaceutical Society of Great Britain in 2000. Dr. Tendler received his Ph.D. from the University of Aston and his Bachelors of Science (First Class Honours) in Pharmacy at the University of Manchester.

"We are delighted to have a distinguished panel of advisors such as Drs. Caskey and Tendler," said Mr. David Sun, President and CEO of Nanogea, "Their extraordinary expertise and background will help guide Nanogea's research and development in the foreseeable future as we expedite our development effort to commercialize our first clinical application for CML (Chronic Myelogeous Leukemia) detection, based on our proprietary NanoCone™ chemistry and NE-AFM™ platform."

About Nanogea
Nanogea, a nano-biotech company located in Westlake Village California, is focused on commercializing the industry's most sensitive genomic and proteomic detection platform based on its innovative NanoCone™ chemistry and NanoCone Enabled Atomic Force Microscopy (NE-AFM™ ) technology. The Company is utilizing its technology to push the genetic and protein detection limit to the single molecular level, thus greatly improving the sensitivity and accuracy of disease diagnosis, prognosis, treatment, and monitoring as well as drug discovery research. To learn more about our pioneering technology, visit www.nanogea.com.

Nanogea Corporation
5716 Corsa Avenue, Suite 201
Westlake Village, CA 91362.
Phone: (818) 889-0538    Fax: (818) 889-0816
E-mail: mlowrey(at)nanogea(dot)com
Website: www.nanogea.com

###

Read the full story at http://www.prweb.com/releases/2009/10/prweb3017444.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. CardioDx Announces Appointment of Dr. Louis G. Lange as Chairman of the Board of Directors
2. IridoTech Announces IridoLab Self Service Kiosk
3. Lexicon Announces Proposed Offering of 27,500,000 Shares of Common Stock
4. NCIIA Announces New Undergraduate Competition
5. Sangamo Announces Pricing of Public Offering of Common Stock
6. Varian, Inc. Announces Stockholder Approval of Merger Agreement With Agilent Technologies
7. Verenium Announces Proposed Public Offering of Common Stock
8. Boston Scientific Announces Exclusive Sponsorship and First Enrollments of MADIT-RIT Clinical Trial
9. YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD., AN AUSTRALIAN CANCER-FOCUSED DEVELOPMENT COMPANY
10. ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME)
11. Oncothyreon announces appointment of Douglas E. Williams, Ph.D., to board of directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Regular discussions on a range of subjects ... the two entities said Poloz. Speaking at a ... , he pointed to the country,s inflation target, which ... "In certain areas ... have common economic goals, why not sit down and address ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... Md. , June 23, 2016 A person ... from the crime scene to track the criminal down. ... the U.S. Food and Drug Administration (FDA) uses DNA evidence ... Sound far-fetched? It,s not. The FDA ... sequencing to support investigations of foodborne illnesses. Put as simply ...
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
Breaking Biology Technology:
(Date:4/19/2016)... , UAE, April 20, 2016 ... be implemented as a compact web-based "all-in-one" system solution ... the biometric fingerprint reader or the door interface with ... of modern access control systems. The minimal dimensions of ... ID readers into the building installations offer considerable freedom ...
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
Breaking Biology News(10 mins):